Transplantation

Article	Citations
313.2: Solitary Pancreas Transplantation - Significant Improvement over the 2 last Decades	156
245.8: Effect of CYP3A5 Genotype-Guided Versus Conventional Initial Dose of Tacrolimus in Children With Kidney Transplants	144
Patient and Provider Gender and Kidney Transplant Referral in Canada: A Survey of Canadian Healthcare Providers	108
328.2: A bioengineered artificial interstitium supports long-term survival of therapeutic xenogeneic porcine islet cells in nonhuman primates without immunosuppression	98
237.2: Synergistic inhibition of human NK cell activation by co-expression of HLA-E and HLA-G on porcine endothelial cells	84
P.13: Effect of human amniotic epithelial cells on intraportal islet transplantation	83
236.3: Improved outcomes following simultaneous pancreas-kidney transplantation in the second decade of the new millennium: a single center longitudinal analysis by era	80
217.6: Beneficial effects of transgenic expression of human CD200 on top of quadruple-knockout/double-knockin (CD46/thrombomodulin) pigs on kidney xenograft survival in nonhuman primates	71
313.1: A novel risk factor for immediate pancreas graft failure: hypertension in the donor	71
236.4: Early differences in glucose homeostasis between diabetes type 1 versus type 2 recipients of kidney/pancreas transplants	69
Prognostic Value of Chest CT Findings at BOS Diagnosis in Lung Transplant Recipients	66
“Digital Tomosynthesis” As a Technique for the Evaluation of Endobronchial Stents in Lung Transplant Recipients	64
Alloreactive Tissue-resident Memory T Cells in Solid Organ Transplantation: Do They Light the Fire?	63
32: 30-year experience of children with Intestinal Failure Associated liver disease	63
Dysbiosis of the Female Murine Gut Microbiome Exacerbates Neutrophil-mediated Vascular Allograft Injury by Affecting Immunoregulation by Acetate	60
Vaccination for HAV: A Lesson From Acute Hepatitis A Superinfection on Chronic B Hepatitis With Lifesaving Living Donor Liver Transplantation for Hepatic Failure	57
Research Highlights	55
209.4: Characterizing the Therapeutic Potential of Human Pluripotent Stem Cell-derived Islet-like Cells Lacking Cell-Surface HLA Expression	53
P.145: Retroperitoneal Pancreas Transplantation With High Duodenojejunal Anastomosis on a Roux-en-Y Loop	53
P.171: Long-term Study of Vascularized Pancreas-on-chip	53
209.3: Treating iPSC-derived β Cells With Monoclonal Antibody Brentuximab Reduces the Risk of Teratoma Upon Transplantation	53
PE-1: “Line Care Governs Our World”: Understanding the Lived Experience of Caregivers of Children with Intestinal Failure on Long-term Parenteral Nutrition	51
Hepatobiliary Scintigraphy to Increase the Safety in Right Lobe Living Donor Liver Transplantation: Not Just a Matter of Age and Remnant Volume	51
*O-30: Stoma-output Reinfusion Device for Ileostomy Patients: A Feasibility Study	51
O-26: Pre- and Peri-transplant Factors Impacting Frequency of Endoscopy after Intestinal Transplantation	49

ILTS 2022 Joint International Congress of ILTS, ELITA & LICAGE, May 4-7, 2022	48
O-46: Cost-utility of Kitelock in Preventing Central Line-associated Blood Stream Infections in Children with Intestinal Failure: A Markov Model	48
The Costs of Organ Procurement: Another Case of Efficiency Versus Equity	47
O-25: A Single-Center, Detailed Report of Malignancies Following Intestinal Transplantation	47
Pneumocystis jirovecii: The Changing Landscape for Prophylaxis	45
The Abundance of Antigalactose-deficient IgA1 Autoantibodies Results in Glomerular Deposition and IgA Nephropathy Recurrence After Renal Transplantation	43
236.8: Early Surgical Complications in Everolimus (EVR) Treated Renal Transplant Recipients	42
332.10: Pre-transplant Coronary Angiography Findings Based on Coronary or Aorto-Iliac Calcification on CT Imaging in Asymptomatic Patients With a Negative Cardiac Stress Test	41
426.5: Regular Physical Activity in the Prevention of Post-transplant Diabetes Mellitus and Associated Metabolic Conditions in Kidney Transplant Recipients	40
425.4: The Role of Role of Sex and T Cells in Natural vs Induced ABO Antibody Production in Mice	40
416.5: Pregnancy-Induced Sensitization in Female Transplant Candidates: HLA-Specific Memory B Cells and Paternal HLA Epitope Mismatch	40
216.14: Validating a Cut-off of IgG Hypogammaglobulinemia as a Risk Factor of Severe Infection in Solid Organ Transplantation	40
P8.112: Pregnancy Outcomes in Kidney Transplant Recipients And Their Newborns	37
P9.35: Application of CRL-Classification (J. Yan ET AL., 2020) Principles for Description of Rare Hepatic Artery Anomalies	37
247.9: Liver Transplantation from Discarded Liver Grafts. A Useful Policy for Expanding the Liver Donor Pool in Mexico	36
240.7: Macrophages and Different Subtypes Infiltrated in Kidney Allografts With Antibody-Mediated Rejection	35
310.8: OVID-Related Neonatal Cholestasis? Liver Transplantation in Three Infants With Perinatal COVID Exposure	35
210.10: Seroconversion After Vaccination With BNT162b2 Pfizer/BioNTech, ChAdOx1 nCoV-19/AZD1222 and Coronavac Against Sars-cov-2 Among Hemodialysis and Kidney Transplant Patients	35
414.3: Review of the Safety and Efficacy of Immunosuppression in the Pig-To-Nonhuman Primate Islet Xenotransplantation Model	34
P2.11: Distinct Global DNA Methylation and NF-κB Expression Profile of Preimplantation Biopsies From Ideal and Non-ideal Kidneys	34
410.5: The Impact of COVID-19 on Renal Function of Kidney Transplant Recipients: A Three-Month Prospective Study	33
313.5: Meeting Packed Red Blood Cell Requirement for the Transmedics Organ Care System (OCS) Liver Transplantation Trial (PROTECT Trial) At Henry Ford Hospital	32
P8.067: Catastrophic EBV Infection After Cadaveric Kidney Transplantation	32
340.11: Flow Cytometric Pattern of Gamma Delta TCR Expression Identifies Outcomes in Kidney Transplantation	32
P8.142: Perturbations in Podocyte Transcriptome and Biological Pathways Induced by Injury Caused by FSGS Associated Circulating Factors	32
316.7: ABO – Incompatible Kidney Transplantation in COVID 19 Era: A Single Centre Experience	31
P11.38: Impact of Two Different TV Content on Promote Organ Donor Registration	31
P10.03: Alternative Surgical Techniques for Abdominal Wall Graft Donation to Guarantee Abdominal Wall Closure in the Donor	31
P8.027: Idiopathic Polymyositis in Renal Transplant Recipient: Case Report and Review of Literature	30
P9.40: Liver Transplantation for Secondary Hemophagocytic Lymphohistiocytosis Associated Acute Liver Failure: A Case Report	30
P5.01: Belt & Road Organ Donation Capacity Improvement Cooperation Training Project (BROAOD)	30
414.10: Cytokine Analysis of First Gal-KO Renal Xenotransplantation From a Pig-To-Human Recipient	30
P17.07: Comparison of Graft Survival Between Full Thickness And Lamellar Pig-To-Monkey Corneal Xenotransplantation From the Same Genetically Engineered Pig With Minimal Immunosuppression	30
364.1: Survival benefit of living donor availability for pediatric liver transplantation in a large North American center: An intention-to-treat analysis.	29
P11.30: Influence of Basic Cardiopulmonary Reanimation on Uncontrolled Donors After Cardiac Death	29
From 6-wk Lungs to 6 y: Increasing the Donor Pool for Pediatric Lung Transplantation	28
Back to Basics: Liver Graft Ischemia in the Era of Machine Perfusion	28
IL-35 Therapy Boosts Treg in Transplantation	28
Prediction and Management of Small-for-size Syndrome in Living Donor Liver Transplantation: Methodology of the ILTS-iLDLT-LTSI Consensus Conference	28
New Allocation Systems: Principles and Processes (Pro)	27
Rethinking Priority for Prodonation Behaviors in Organ Allocation—Lessons From the Israeli Experience	27
Improved Waitlist Outcomes in Liver Transplant Patients With Mid-MELD-Na Scores Listed in Centers Receptive to Use of Organs Donated After Circulatory Death	27
CXCR5+CD8+ T Cell–Mediated Suppression of Humoral Alloimmunity and AMR in Mice Is Optimized With mTOR and Impaired With Calcineurin Inhibition	27
The Challenges of Risk Aversion in Kidney Transplantation: Lessons From the SARS-CoV-2 Pandemic in Brazil	27
P.370: Correction of portal vein stenosis in patients following living donor liver transplantation.	26
P.488: Pediatric liver transplantation in Situs inversus and other vascular abnormalities.	26
405.2: Kidney transplantation in patients with intellectual disability.	26
P.506: Outcome of heart transplant in a young patient referred with cardiogenic shock and multi-organ failure.	26
403.3: Beyond kidney donation: Unveiling predictors of long-term kidney function in living donors.	26
P.493: Utilization of mechanical assist devices in pediatric patients with end-stage heart failure.	26

P.303: An exploratory study of patient-provider communication during the medical evaluation for kidney transplantation.	25
247.11: Comparative assessment of steatotic livers in preservation solutions: New compositions for old problems.	25
320.12: The outcomes of renal transplantation in congenital chloride diarrhea- A cases series.	25
322.4: Engineering pancreatic islet grafts with innate immune modulators to mitigate instant blood-mediated inflammatory reaction.	25
V-210.3: Paired kidney exchange program: A utilitarian service to the underserved populations in the northern great plains of the United States.	25
247.5: Mitochondrial flavin mononucleotide measured at beginning of hypothermic machine perfusion predicts patient survival after liver transplantation.	25
P.197: Patient’s death with a functioning graft (DWF) from infection is a major cause of renal transplant loss – A retrospective study from a single center.	25
P.044: Rhabdomyolysis after cooked local fish consumption (Haff Disease) in kidney transplant in South of Brazil - Case report.	25
P.086: Endoplasmic reticulum stress in recipient spleen follicular B lymphocytes in transplantation may affect the alloimmune response of T lymphoctes.	25
Never Say Never: The Latest Immune Rejection Ever Reported 51 y After Corneal Transplantation	25
300.4: First experience of extracorporeal-cardiopulmonary resuscitation program and its impact in kidney transplant.	24
Dynamics of Humoral and Cellular Responses in Renal Transplant Recipients Receiving 3 Doses of SARS-CoV-2 mRNA Vaccine	24
Beyond Adaptive Alloreactivity: Contribution of Innate B Cells to Allograft Inflammation and Rejection	24
440.2: Clinical study of the importance of IgG level in kidney transplant recipient.	24
410.4: A prospective observational study to assess the role of donor derived cell free DNA (dd-cfDNA) in predicting active rejection in renal allograft recipients.	24
264.9: GSK3β deficiency ameliorates hepatic ischemia-reperfusion injury by regulating necroptosis of kupffer cells.	24
410.3: Anti-MICA antibodies and graft outcomes in kidney transplant recipients.	24
What Can the Developing World (and Others) Learn From the Indian Experience in Crossing the ABO Blood Group Barrier in Kidney Transplantation	23
Highlights From Controversies in Transplantation 2023 Conference	23
P.345: Biliary sludge and complications in multivisceral transplantation patients.	23
How to Deal With Kidney Retransplantation—Second, Third, Fourth, and Beyond	23
Progress Update on the Transplant Surgery Training Pipeline in the United States	23
P.425: Kidney donation and kidney transplantation among Ukrainians in Poland within two years of war in Ukraine.	23
Outcomes of Coccidioides Seropositive Solid Organ Transplant Recipients After Self-discontinuation of Antifungal Prophylaxis: The EIA-IgM-only Conundrum	23
Unraveling Molecular and Functional Responses Across 3 Lung Injury Models to Expand the Donor Lung Pool	23
P.333: Interferon-gamma release test results in organ transplant recipients and donors at Başkent University Faculty of Medicine Hospital.	23
366.1: iRhom2 regulates hepatocyte senescence in ischemia/reperfusion injury by modulating HMGB1 secretion.	23
Research Highlights	22
Innate-like B Cells: Local Drivers of Non-HLA Immunity in Rejecting Kidney Allografts?	22
116.5: Empowering organ donation advocates through online grass-root level volunteer training: ‘the organ donation ambassadors program’	22
Donor-derived Cell-free DNA and Acute Kidney Rejection: A Golden Opportunity or a False Hope?	22
Renal Transplantation in the Dominican Republic: Achievements, Challenges, and Gender Disparities	22
123.7: How to increase organ and tissue donation with a low budget and better approach	22
P1.1: Laryngotracheal transplant: Patient and caregivers’ beliefs and perceptions	22
Integrative Analysis of Prognostic Biomarkers for Acute Rejection in Kidney Transplant Recipients: Erratum	22
P8.6: A historical review of heart transplantation in Saudi Arabia: trends, progress, and heart valve utilization	22
P4.5: Red cell distribution width (RDW): A prognosis indicator of brain death in patients with GCS<6	22
Senotherapy: Implications for Transplantation	21
Research Highlights	21
Liver Retransplantation Using Living Donor Grafts: A Feasible Approach for Chronic Allograft Failure	20
Using Regression Equations to Enhance Interpretation of Histology Lesions of Kidney Transplant Rejection	20
P.240: Advanced chronic kidney disease in kidney transplant recipients: A national cross-sectional cohort study.	20
Bile Chemistry During Ex Situ Normothermic Liver Perfusion Does Not Always Predict Cholangiopathy	20
Amplified Natural Killer Cell Activity and Attenuated Regulatory T-cell Function Are Determinants for Corneal Alloimmunity in Very Young Mice	19
Cold Storage Disrupts the Proteome and Phosphoproteome Landscape in Rat Kidney Transplants	19
Determinants of Immune Response to Anti–SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients: A Prospective Cohort Study	19
P3.05: Apraglutide Decreases Severity of Intestinal Damage From Acute Gastrointestinal Graft Versus Host Disease (GI-GvHD) Following Allogeneic Transplantation Without Impacting Engraftment	19
337.5: Islet transplantation versus insulin alone in type 1 diabetic kidney transplant recipients: a French nationwide study on behalf of the TREPID group	19
47: 10 Years’ Experience of Transplant Oncology in the Management of Unresectable Desmoid Tumor: One-staged or Two-staged Approach	19
Outcomes of Solid Organ Transplant Recipients Treated With Antispike Monoclonal Antibodies for Coronavirus Disease 2019 Across Variant Epochs: Impact of Comorbidities and Vaccination	19
P12.15: Dapagliflozin for the Treatment of Post-transplant Diabetes Mellitus After Pancreas Transplantation: A Case Report With A 14-Month Follow-up	19
Insight Into Current BK Polyomavirus Research Efforts: BK Day Meeting 2024	19
Adenovirus Infection and Transplantation	19
Home-based LIver FrailTy Intervention (LIFT) in Transplant Candidates: A Feasibility Study	19
The Case for Prolonged ECMO for COVID-19 ARDS as a Bridge to Recovery or Lung Transplantation	19
Psychometric Properties of the BAASIS: A Meta-analysis of Individual Participant Data	19
Can We Use Eplets (or Molecular) Mismatch Load Analysis to Improve Organ Allocation? The Hope and the Hype	19
The Clinical and Economic Benefit of CMV Matching in Kidney Transplant: A Decision Analysis	19
Minimizing Metabolic and Cardiac Risk Factors to Maximize Outcomes After Liver Transplantation	18
Utility of OPO Procurement Surgeons in Reducing Discards of Marginal Liver Allografts	18
Amelioration of Diabetes and Neuropathy After Pancreas Transplantation: Measurable Differences in Vibration Perception Thresholds Impact Outcomes	18
16: RNA Sequencing (RNA-seq) Analysis Provides for Gene Signatures Specific to Intestinal Transplant Rejection	18
Chronic Rejection After Kidney Transplantation	18
Commentary on “Infection Risk in the First Year After ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort Study”	18
Muhammad M. Mohiuddin, MBBS (MD), DSc (Hon)	18
Replacing the Endomyocardial Biopsy: Easier Said Than Done	18
Chimerism-based Tolerance Induction in Clinical Transplantation: Its Foundations and Mechanisms	18
Meeting Report: The Sixth International Sam Strober Workshop on Clinical Immune Tolerance	18
113: Complications of vascular Ehlers-Danlos Syndrome: Management by an Intestinal Failure Multidisciplinary Team	18
105.2: Novel subcutaneous islet transplantation method using a bioabsorbable medical device to facilitate the guidance of the highly vascularized transplantation site	17
317.1: Perceptions and potential barriers of personnel involved in xenotransplant research	17
P-65: Visceral Transplantation for Pediatric Patients with Rare Genetic Syndromes	17
120.4: Preventable harm in the Canadian organ donation and transplantation system (semi colon) a descriptive study of missed organ donor identification and referral	17
121.5: The development progress of “the Shanxi Model”: the first independent provincial OPO in China	17
P8.020: Incidence and Correlates of Testicular Pain After Kidney Donation	17
Deceased Organ Donation and Transplantation in the United Arab Emirates: A View 7 y After Implementation	17
123.8: Spotlight on relatives of tissue donors - what factors influence the decision-making process?	17
106.5: Comparison of open surgery and ultrasound-guided percutaneous injection on the cytokine response to pig islet xenotransplantation	17
122.6: Increasing kidney utilization	17
Long-term Comparison of Everolimus and Mycophenolate in Tacrolimus-based and Steroid-free Immunosuppressive Regimen	17

P15.10: The Impact of Different Induction Immunosuppression Protocol on Patient Survival, Graft Survival and Acute Graft Rejection After Kidney Transplantation – Multicenter Study	17
P-46: Gallstones in Children on Long-term Parenteral Nutrition	17
PE-8: Relation Between Surgical Procedures, Chronic Intestinal Failure and Dependency on Parenteral Support	17
P3.3: Consider the causes of low organ donation in Japan by the GCS3 registry	17
211.3: Donor prostate cancer should not be contraindication for donation of kidney	17
Personality Traits in Patients With Cirrhosis Are Different From Those of the General Population and Impact Likelihood of Liver Transplantation	17
P9.5: Organ donation between personal and cultural beliefs in Saudi Arabia	17
243.9: Equality and Equity in Transplant for Children	16
210.12: Booster Shots and Additional Doses for COVID-19 in Solid Organ Recipients	16
P9.10: Mono-Maintenance Therapy With Anti-icam-1 Monoclonal Antibody Induced Long-term Liver Allograft Survival in Nonhuman Primates	16
421.5: Extracorporeal Membrane Oxygenation Use in Orthotopic Liver Transplantation as a Viable Bridge to Transplant and Tool For Intraoperative and Postoperative Rescue	16
P8.052: Long-term Outcomes and Predictors of Graft Function in Living-Donor Preemptive Kidney Transplants	16
P8.099: Post-operative Myocardial Infarction After Renal Transplant: Setback or Disaster?	16
216.4: Wide Spectrum of Molecular Injury Highlights Heterogeneity of Banff Tubulitis and Interstitial Inflammation Lesions	16
334.3: Presentation of FasL Protein by PEG Microgels Within Graft Site Leads to Survival of Pancreatic Islets in Nonhuman Primates Without the Need for Chronic Immunosuppression	16
241.2: A Worldwide Survey of Activities and Practices in Clinical Islet of Langerhans Transplantation	16
P12.11: Immunomodulatory Microporous Annealed Particle (MAP) Gel Protects Delivery of Islets to Promote Islet Transplantation Outcomes	16
242.7: Influence of CYP3A5 Polymorphisms on Tacrolimus Dosing in Renal Transplant Recipients	16
P14.07: Use of Grafts With Extended Ischemic Time (Above 4 Hours Or More): Analysis of the Experience of the Largest Brazilian Heart Transplant Center, From 2013 to 2022	16
241.1: Maturation and Evaluation of 3D Printed Bionic Pancreas With a Dedicated Bioreactor	16
246.2: Novel Avenue of Allograft Monitoring: Direct Measurement of Donor-Derived Extracellular Vesicles in Human Plasma	16
P8.086: Persistent Hyperparathyroidism Post Renal Transplantation	16
213.4: Single-dose Rituximab Induction May Prevent EBV Viremia in Paediatric Kidney Recipients Long-term: An Investigation From the Nordic Paediatric Renal Transplantatioinn Study Group	16
317.1: Personalized Approach to Risk-Stratified Desensitization in Modified Multivisceral Transplantation	16
P3.02: Assessment of Chimerism Testing by Next Generation Sequencing	16
P8.135: Machine Learning in Kidney Transplantation: A New Possibility For the Graft Survival Prediction	16
235.2: Prediction of Acute Rejection Post-kidney Transplant: An Artificial Intelligence Approach	16
343.10: A Novel Approach for Pancreas Transplant With Arterial Patch	16
245.8: Shiraz Transplant Center; leader of the intestinal transplant in the Middle East; challenges and opportunities.	15
343.3: Up-regulated LRRN2 expression is effective as a marker for graft quality in living donor liver transplantation.	15
344.7: Predictive analysis of new-onset diabetes after kidney transplantation: Integrating clinical and radiological factors at Mayo Clinic.	15
312.1: Implementation of Longitudinal Portoplasty for Hypoplasic Portal Veins in Children With Biliary Atresia in a Liver Transplantation Centre in Argentina	15
247.6: Preliminary Results of Ex-vivo Normothermic Machine Perfusion in Deceased Donor Renal Allograft Transplantation – First Clinical Experience From Asia	15
246.8: In Vivo Monitoring of Liver Organoids Differentiation Using Live-Screening-Optical Technologies	15
317.9: Report of a Case of Double Arm Transplantation Including Left Shoulder Reconstruction	15
261.12: Novel system for organ preservation: Feed macrophages Ceria nanoparticles.	15
P.357: The effects of early postoperative thrombocytopenia at intensive care unit admission to allograft function and outcomes after liver transplantation.	15
P.175: Correlation of early graft dysfunction and baseline doppler ultrasound result.	15
211.8: Impact of Sarcopenia Using Anterior Thigh Skeletal Muscle Index on Clinical Outcomes in the Liver Transplant Recipient	15
400.1: The “Global Kidney Exchange” Proposal Is Impractical And Not Financially Neutral	15
411.5: Autophagy Mediates Liver Functional Recovery From Donation After Circulatory Death Rats With Normothermic Machine Perfusion	15
P.100: Are transfusion reactions associated with hematopoietic stem cell product infusion more frequent than previously thought?	15
264.4: Macrophage SETDB1 reduces inflammatory macrophage infiltration by inhibiting P2rx7 expression and alleviates liver ischemia-reperfusion injury.	15
P.464: Social and structural disparity in possible organ donor discards in Chile.	15
412.3: The Performance of the Kidney Donor Profile Index in Predicting Outcomes for Brazilian Kidney Transplant Recipients of Standard Criteria Donors	15
416.1: Impact of HLA-A,B DR and DQ on Deceased Kidney Transplant Outcomes in the Tacrolimus/MMF Era: An Artificial Intelligence Approach	15
C-peptide Targets and Patient-centered Outcomes of Relevance to Cellular Transplantation for Diabetes	15
261.13: The setup used for ex vivo renal normothermic perfusion influences a kidney’s behavior on the pump.	14
P.178: Immunologic risk stratification of kidney transplant recipients by combining HLA-eplet MM and PIRCHE-II.	14
236.2: Simultaneous kidney-pancreas transplantation improves endothelial dysfunction induced by extracellular vesicles	14
336.5: Modifying The Porcine Genome for Xeno-organ Transplantation	14
320.15: Recurrence of focal segmental glomerulosclerosis among kidney transplant recipients: Kuwait experience.	14
237.4: Evaluation of immune reactions in multi-knockout kidneys after perfusion with human blood	14
Use of Federal Reimbursement for Living Donor Costs by Racial and Ethnic Minorities: Implications for Disparities in Access to Living Donor Transplantation	14
337.4: Islet-alone vs. islet-after-kidney transplantation glycemic outcomes: Report from the Collaborative Islet Transplant Registry	14
An Intention-to-treat View of Lung Transplantation for Interstitial Lung Disease: Successful Strategies to Minimize Waiting List and Posttransplant Mortality	14
P.041: Switching from ciclosporin to tacrolimus as de novo calcineurin inhibitor in lung transplantation: First results of a multidisciplinary quality assurance project.	14
241.9: Evaluation of renal allograft biopsy results and long-term allograft survival in kidney transplant recipients: Baskent University experience.	14
P.077: Engineered mesenchymal stem cell-mediated release of the chemokine CCL28 remodels the immune microenvironment to resist graft rejection.	14
117.6: Can pyelonephritis initiate antibody-mediated rejection (AMR) of a pig xenograft?	14
328.5: Islet encapsulation preserves their functionality following transplantation into immunocompetent diabetic animals without immunosuppression	14
The Mycophenolate-based Immunosuppressive Regimen Is Associated With Increased Mortality in Kidney Transplant Patients With COVID-19	13
Invited Response to Letter to the Editor by Callaghan et al, “Following the Flow: Changes in Organ Preservation Methods Require Changes in Our Data Collection”	13
Imlifidase Desensitization in HLA-incompatible Kidney Transplantation: Finding the Sweet Spot	13
Immune Monitoring Assays: Predicting Cytomegalovirus and Other Infections in Solid Organ Transplant Recipients	13
229.7: The role of sex hormones in the intestinal injury after brain death using a surgical menopause model in rats.	13
Incidence of Acute Rejection Compared With Endomyocardial Biopsy Complications for Heart Transplant Patients in the Contemporary Era	13
Diagnostic and Therapeutic Implications of Ex Vivo Lung Perfusion in Lung Transplantation: Potential Benefits and Inherent Limitations	13
210.6: Development and dissemination of a unique virtual reality training program to improve physician skill, knowledge and confidence in determining brain death and family communication	13
208.2: Over 1,000 Pancreas Transplantation in a Latin American Program	13
344.3: An Inconvenient Offer: A Single OPOs Experience in Kidney Utilization.	13
204.5: Pediatric kidney transplantation in the Middle East: Challenges and solutions.	13
Three-dimensional Vascularized β-cell Spheroid Tissue Derived From Human Induced Pluripotent Stem Cells for Subcutaneous Islet Transplantation in a Mouse Model of Type 1 Diabetes	13
MHC Tetramers Specifically Identify High- and Low-avidity Donor-specific B Cells in Transplantation Tolerance and Rejection	13
118.8: Understanding pancreas-machine interactions during preservation: A mathematical approach	13
Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in Transplantation	13
313.12: Hypothermic Oxygenated Machine Perfusion of an En-Bloc Dual Kidney Specimen: Proof of Concept, in an Animal DCD Model, of a New Option to Preserve and Evaluate Kidney Grafts	13
Desensitization in Crossmatch-positive Kidney Transplant Candidates	13
Identification of Differentially Expressed Genes in Cold Storage–associated Kidney Transplantation	13
ABO Antibody Development, a New Look at a Very Old Question	13
The Nuances of Hand Transplantation After Sepsis	13
228.8: Artificial pancreatic islets produced by 3D bioprinting ink-jet technology with extracellular matrix as an environment for stem-cell derived beta cells.	13
400.2: Long-term insulin independence following allogenic islet transplant and childbirth	12
Integrating APOL1 Kidney-risk Variant Testing in Live Kidney Donor Evaluation: An Expert Panel Opinion	12
Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients	12
312.4: Exploring local immune modulation with rapamycin-eluting microparticles to preserve islet graft function in mice	12
Cutting the Ice in Donor Heart Preservation	12
Donor-derived Cell-free DNA as a Noninvasive Biomarker of Kidney Allograft Rejection in Pediatric Kidney Transplantation	12
201.4: Islet stressomes released during isolation and in response to inflammation may affect outcomes in islet auto-transplantation	12
202.2: Islet xenotransplantation with quadruple knock-out porcine islet enhanced graft survival in diabetic mice	12
108.1: Comparative analysis of survival rates between single GTKO and TKO pig to monkey kidney xenotransplantation	12
Standardized Patient-centered Approach to Perioperative Antibiotics in Liver Transplantation	12
P.21: Reproductive ability of minipigs as surrogates for somatic cell nuclear transfer	12
215.5: Human Amnion Epithelial Cells reduce disease progression in a mouse model for multiple sclerosis	12
108.3: A transgenic strategy for hEPCR expression in porcine endothelial cells	12